Paraquat Intoxication – experience of an Internal Medicine ward for 18 years

Authors

  • Marco Simões Serviço de Medicina Interna dos Hospitais da Universidade de Coimbra
  • Patrícia Alves Serviço de Medicina Interna dos Hospitais da Universidade de Coimbra
  • Hélder Esperto Serviço de Medicina Interna dos Hospitais da Universidade de Coimbra
  • Catarina Canha Serviço de Medicina Interna dos Hospitais da Universidade de Coimbra
  • Elisa Meira Serviço de Medicina Interna dos Hospitais da Universidade de Coimbra
  • Érica Ferreira Serviço de Medicina Interna dos Hospitais da Universidade de Coimbra
  • Manuel Gomes Serviço de Medicina Interna dos Hospitais da Universidade de Coimbra
  • José Manuel Nascimento Costa Serviço de Medicina Interna dos Hospitais da Universidade de Coimbra

Keywords:

Paraquat, Intoxication, hemocarboperfusion, Herbicide, Gramoxone, cyclophosphamide

Abstract

Introduction: Paraquat is a contact herbicide commercially available since 1962. Paraquat intoxication (PI) is usually voluntary
and highly lethal, since there is no effective antidote. Toxicity
occurs through cyclic redox reactions, damaging mainly the
kidneys and lungs.
Aim, material and methods: featuring the clinical presentation,
management and outcome of patients with PI over an 18 years
period (from the 01st January 1993 to the 31st December 2010)
through the retrospective analysis of clinical files and comparing
the survivors and the deceased.
Results: Thirty-one cases of Paraquat intoxication were included, with a male: female ratio 1:1. Age range from 13 to 80 years,
mean age 42.4years (±18.7).All intoxications were voluntary and
by oral route. There was statistical difference in the amount ingested (22.1 mL vs. 72.7 mL, p<0.0005). A non-significant trend
to a longer delay until getting medical attention in the deceased
group (1.6 h vs. 3.2 h, p=0.091). Statistical significance was found
between mortality and leukocytosis, hypocapnea, hypoxemia, LDH,
alkaline phosphatase and AST. There was no difference between
groups according to treatment options, although hemocarboperfusion was used more often in the deceased group (53.9%
vs. 66.7%, p=0.471) and corticosteroids in the survivor group
(61.5% vs. 44.4%, p=0.350). Mortality rate was 58.1% (66.7%
in the first 72 hours), due to respiratory insufficiency and multiple
organ failure. Variable levels of pulmonary fibrosis occurred in
38.5% of the survivors.
Discussion & Conclusion: Paraquat intoxication has a poor
prognosis with limited efficiency of treatment approaches. The
relation between Paraquat in the urine and the time elapsed after
ingestion is the main determinant factor in the prognosis. In this
study the presence of dyspnea, hypocapnea and hypoxemia was
linked to a bad prognosis. There was no statistical difference
between the available treatment options.

Downloads

Download data is not yet available.

References

Dinis-Oliveira RJ, Duarte JA, Sánchez-Navarro A, Remião F, Bastos ML, Carvalho F. Paraquat Poisonings: Mechanisms of Lung Toxicity, Clinical Features, and Treatment. Crit Ver Toxicol 2008; 38(1): 13-71.

Bullivant CM. Accidental poisoning by paraquat: Report of two cases in man. Br Med J 1966;1(5498): 1272-1273.

Almeida MI, Rato F, Dias MJ, Carvalho MC. Avaliação das Intoxicações por Paraquato em Portugal no Período de 2004 a 2006. Rev Fac Ciências da Saúde 2009; 6: 272-282.

Castro R, Prata C, Oliveira L et al. Intoxicação por Paraquato e Terapêutica com Hemocarboperfusão. Acta Med Port 2005; 18: 423-432.

Li LR, Sydenham E, Chaudhary B, You C. Glucocorticoid with cyclophosphamide for paraquat-induced lung fibrosis. Cochrane Database of Systematic Reviews 2010; 6: 1-19.

Serra A, Domingos F, Prata MM. Intoxicação por Paraquat. Act Med Port 2003; 16: 25-52.

Santos JM, Santos A, Simão A, Almiro E, Severo F, Porto A. Intoxicação pelo Paraquat - Casuística dum Serviço de Medicina Interna. Rev Port Med Interna 1996; 3(2): 74-80

Branco V, Calretas S, Simão A et al. Intoxicação pelo Paraquat - Casuística dum Serviço de Medicina Interna. Rev Port Med Interna 2001; 8(2): 71-75.

Dinis-Oliveira RJ, Pinho PG, Santos L et al. Postmortem analyses unveil the poor efficacy of decontamination, anti-inflammatory and immunosuppressive therapies in paraquat human intoxications. PLoS One 2009; 4(9): e7149.

Agarwal R, Srinivas R, Aggarwal NA, Gupta D. Immunosuppressive therapy in lung injury due to paraquat poisoning: a meta-analysis. Singapore Med J 2007; 48(11): 1000-1005.

Eddleston M, Wilks MF, Buckley NA. Prospects for treatment of paraquat-induced lung fibrosis with immunosuppressive drugs and the need for better prediction of outcome: a systematic review. Q J Med 2003; 96: 809–824.

Hong SY, Yang JO, Lee EY, Kim SH. Effect of haemoperfusion on plasma paraquat concentration in vitro and in vivo. Toxicol Ind Health 2003; 19(1): 17-23.

Afzali S, Gholyaf M. The effectiveness of combined treatment with methylprednisolone and cyclophosphamide in oral Paraquat poisoning. Arch Iranian Med 2008; 11(4): 387-391.

Lin JL, Lin-Tan DT, Chen KH et al. Improved survival in severe paraquat poisoning with repeated pulse therapy of cyclophosphamide and steroids. Intensive Care Med 2011; 37(6): 1006-1013.

Dinis-Oliveira RJ, Sousa C, Remião F et al. Full survival of paraquat-exposed rats after treatment with sodium salicylate. Free RadicBiol Med

; 42(7): 1017-1028

Additional Files

Published

2012-06-29

How to Cite

1.
Simões M, Alves P, Esperto H, Canha C, Meira E, Ferreira Érica, Gomes M, Nascimento Costa JM. Paraquat Intoxication – experience of an Internal Medicine ward for 18 years. RPMI [Internet]. 2012 Jun. 29 [cited 2024 Dec. 18];19(2):69-73. Available from: https://revista.spmi.pt/index.php/rpmi/article/view/1142

Issue

Section

Original Articles

Most read articles by the same author(s)